Clinical Trial Update: Ceftaroline in the Treatment of Bone and Joint Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ceftaroline fosamil for bone and joint infections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteomyelitis
• Septic Arthritis

Drugs mentioned

• ceftaroline fosamil (ceftaroline fosamil)

Snippet

Sponsor: Orlando Health, Inc. | Conditions: Osteomyelitis, Joint Infections | Phase 4 | Status: WITHDRAWN